Advertisement

Gilead Sciences, Inc. GILD

Set alert

Price alert · GILD

All alert types
170.68 USD +5.07 +3.06%

At close · Oct 30

170.73 +0.05 +0.03%

After hours · Oct 30, 7:59 PM ET

Bid
170.72 × 1
Ask
170.85 × 1
169.00 Day range 175.65
118.15 52-week range 170.68
YTD
+39.06%
1 year
+44.11%
Open
170.00
Prev close
165.61
Mkt cap
211.81B
Vol
11.43M
Avg vol
6.04M
EPS
-2.65
P/E
0.00
Div yield
1.98%
More statistics
Low
169.00
High
175.65
Forward P/E
17.22
Beta
0.33
Short ratio
3.40
Inst. own
91.98%
Dividend
3.28
Ex-div date
Sep 14, 2026
Earnings
Feb 9, 2027
50-d avg
150.33
200-d avg
139.65
1y target
160.19

5D chart

Chart tools
Interval

Events in this range
  • Oct 29, 2026Earnings: 2.55; estimate 2.19; surprise 16.44%
  • Oct 30, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
  • Oct 30, 2026Rating: RBC Capital · Sector Perform → Sector Perform
  • Oct 30, 2026Rating: Truist Securities · Buy → Buy
  • Oct 30, 2026Rating: Wells Fargo · Overweight → Overweight
  • Oct 30, 2026Rating: Morgan Stanley · Overweight → Overweight
  • Oct 30, 2026Rating: TD Cowen · Buy → Buy
Signals (144)
NameTimeAgo
SMA: BearishOct 30, 3:55 PM1 day ago
MACD: Sell SignalOct 30, 3:55 PM1 day ago
MACD: Buy SignalOct 30, 3:45 PM1 day ago
SMA: BullishOct 30, 3:40 PM1 day ago
SMA: BearishOct 30, 2:35 PM1 day ago
SMA: BearishOct 30, 2:35 PM1 day ago
SMA: BullishOct 30, 2:15 PM1 day ago
SMA: BearishOct 30, 2:10 PM1 day ago
SMA: BullishOct 30, 1:50 PM1 day ago
SMA: BearishOct 30, 1:40 PM1 day ago
SMA: BullishOct 30, 1:15 PM1 day ago
SMA: BullishOct 30, 12:55 PM1 day ago
SMA: BearishOct 30, 12:50 PM1 day ago
SMA: BearishOct 30, 12:50 PM1 day ago
SMA: BullishOct 30, 12:15 PM1 day ago
SMA: BullishOct 30, 12:05 PM1 day ago
SMA: BearishOct 30, 11:40 AM1 day ago
SMA: BearishOct 30, 11:25 AM1 day ago
SMA: BullishOct 30, 10:50 AM1 day ago
MACD: Sell SignalOct 30, 10:30 AM1 day ago
SMA: BearishOct 30, 10:25 AM1 day ago
SMA: BullishOct 30, 10:20 AM1 day ago
RSI: OverboughtOct 30, 10:20 AM1 day ago
SMA: BearishOct 30, 10:15 AM1 day ago
RSI: OverboughtOct 29, 3:15 PM2 days ago
SMA: BullishOct 29, 2:35 PM2 days ago
SMA: BullishOct 29, 2:30 PM2 days ago
SMA: BearishOct 29, 2:20 PM2 days ago
SMA: BearishOct 29, 2:20 PM2 days ago
SMA: BullishOct 29, 1:50 PM2 days ago
MACD: Buy SignalOct 29, 1:45 PM2 days ago
SMA: BullishOct 29, 1:40 PM2 days ago
SMA: BearishOct 29, 12:55 PM2 days ago
SMA: BullishOct 29, 12:45 PM2 days ago
SMA: BearishOct 29, 12:35 PM2 days ago
SMA: BullishOct 29, 12:20 PM2 days ago
SMA: BearishOct 29, 11:45 AM2 days ago
SMA: BearishOct 29, 11:30 AM2 days ago
SMA: BullishOct 29, 11:15 AM2 days ago
SMA: BullishOct 29, 11:10 AM2 days ago
SMA: BearishOct 29, 11:05 AM2 days ago
SMA: BullishOct 29, 11:00 AM2 days ago
SMA: BearishOct 29, 10:55 AM2 days ago
MACD: Sell SignalOct 29, 10:30 AM2 days ago
SMA: BearishOct 29, 10:15 AM2 days ago
SMA: BullishOct 29, 9:30 AM2 days ago
RSI: OverboughtOct 29, 9:30 AM2 days ago
SMA: BearishOct 28, 3:50 PM3 days ago
SMA: BullishOct 28, 3:30 PM3 days ago
MACD: Buy SignalOct 28, 3:25 PM3 days ago
SMA: BullishOct 28, 3:15 PM3 days ago
RSI: OversoldOct 28, 2:35 PM3 days ago
SMA: BearishOct 28, 2:20 PM3 days ago
MACD: Sell SignalOct 28, 2:20 PM3 days ago
SMA: BullishOct 28, 2:15 PM3 days ago
SMA: BearishOct 28, 2:05 PM3 days ago
SMA: BearishOct 28, 2:05 PM3 days ago
SMA: BullishOct 28, 1:45 PM3 days ago
MACD: Buy SignalOct 28, 1:30 PM3 days ago
SMA: BullishOct 28, 1:20 PM3 days ago
SMA: BearishOct 28, 12:55 PM3 days ago
SMA: BullishOct 28, 12:50 PM3 days ago
SMA: BearishOct 28, 12:40 PM3 days ago
SMA: BullishOct 28, 12:35 PM3 days ago
SMA: BearishOct 28, 12:00 PM3 days ago
SMA: BearishOct 28, 11:40 AM3 days ago
SMA: BullishOct 28, 11:30 AM3 days ago
SMA: BearishOct 28, 11:05 AM3 days ago
MACD: Sell SignalOct 28, 11:05 AM3 days ago
MACD: Buy SignalOct 28, 9:45 AM3 days ago
SMA: BullishOct 28, 9:40 AM3 days ago
SMA: BullishOct 28, 9:40 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
MACD: Sell SignalOct 28, 9:30 AM3 days ago
RSI: OverboughtOct 27, 3:50 PM4 days ago
MACD: Buy SignalOct 27, 3:00 PM4 days ago
SMA: BullishOct 27, 2:50 PM4 days ago
SMA: BullishOct 27, 2:45 PM4 days ago
SMA: BearishOct 27, 2:25 PM4 days ago
SMA: BearishOct 27, 2:20 PM4 days ago
SMA: BullishOct 27, 2:15 PM4 days ago
MACD: Sell SignalOct 27, 1:50 PM4 days ago
SMA: BearishOct 27, 1:40 PM4 days ago
SMA: BullishOct 27, 12:10 PM4 days ago
SMA: BearishOct 27, 12:05 PM4 days ago
SMA: BullishOct 27, 12:00 PM4 days ago
SMA: BullishOct 27, 12:00 PM4 days ago
MACD: Buy SignalOct 27, 12:00 PM4 days ago
SMA: BearishOct 27, 11:55 AM4 days ago
SMA: BearishOct 27, 11:55 AM4 days ago
SMA: BullishOct 27, 11:50 AM4 days ago
SMA: BullishOct 27, 11:50 AM4 days ago
MACD: Sell SignalOct 27, 11:45 AM4 days ago
SMA: BearishOct 27, 11:40 AM4 days ago
SMA: BearishOct 27, 11:40 AM4 days ago
SMA: BullishOct 27, 11:35 AM4 days ago
SMA: BullishOct 27, 11:35 AM4 days ago
SMA: BearishOct 27, 11:30 AM4 days ago
SMA: BearishOct 27, 11:25 AM4 days ago
SMA: BullishOct 27, 11:15 AM4 days ago
SMA: BullishOct 27, 11:15 AM4 days ago
SMA: BearishOct 27, 11:10 AM4 days ago
SMA: BearishOct 27, 11:05 AM4 days ago
SMA: BullishOct 27, 10:45 AM4 days ago
MACD: Buy SignalOct 27, 10:30 AM4 days ago
SMA: BullishOct 27, 10:25 AM4 days ago
SMA: BearishOct 27, 10:20 AM4 days ago
SMA: BearishOct 27, 9:30 AM4 days ago
SMA: BearishOct 27, 9:30 AM4 days ago
MACD: Sell SignalOct 27, 9:30 AM4 days ago
RSI: OversoldOct 27, 9:30 AM4 days ago
SMA: BullishOct 26, 3:25 PM5 days ago
SMA: BullishOct 26, 3:20 PM5 days ago
MACD: Buy SignalOct 26, 3:20 PM5 days ago
SMA: BearishOct 26, 3:15 PM5 days ago
SMA: BullishOct 26, 3:10 PM5 days ago
MACD: Sell SignalOct 26, 2:40 PM5 days ago
SMA: BearishOct 26, 2:35 PM5 days ago
SMA: BearishOct 26, 2:20 PM5 days ago
SMA: BullishOct 26, 2:15 PM5 days ago
SMA: BearishOct 26, 2:05 PM5 days ago
SMA: BullishOct 26, 2:00 PM5 days ago
SMA: BullishOct 26, 2:00 PM5 days ago
MACD: Buy SignalOct 26, 2:00 PM5 days ago
SMA: BearishOct 26, 1:45 PM5 days ago
MACD: Sell SignalOct 26, 1:45 PM5 days ago
MACD: Buy SignalOct 26, 1:40 PM5 days ago
SMA: BullishOct 26, 1:35 PM5 days ago
MACD: Sell SignalOct 26, 1:15 PM5 days ago
SMA: BearishOct 26, 1:05 PM5 days ago
SMA: BullishOct 26, 12:50 PM5 days ago
SMA: BearishOct 26, 12:35 PM5 days ago
SMA: BearishOct 26, 12:35 PM5 days ago
SMA: BullishOct 26, 12:30 PM5 days ago
SMA: BullishOct 26, 12:30 PM5 days ago
SMA: BearishOct 26, 12:25 PM5 days ago
SMA: BearishOct 26, 12:25 PM5 days ago
SMA: BullishOct 26, 12:10 PM5 days ago
SMA: BullishOct 26, 12:05 PM5 days ago
SMA: BearishOct 26, 12:00 PM5 days ago
SMA: BullishOct 26, 11:30 AM5 days ago
SMA: BearishOct 26, 10:25 AM5 days ago
SMA: BullishOct 26, 10:20 AM5 days ago

Key statistics

Market cap
211.81B
Enterprise value
226.63B
Trailing P/E
0.00
Forward P/E
17.22
PEG ratio
2.45
Price / sales
6.95
Price / book
9.33
EPS (TTM)
-2.65
Beta
0.33
Dividend yield
1.98%
Payout ratio
43.46%
Profit margin
-10.64%
Revenue (TTM)
30.46B
Revenue growth
10.20%
Free cash flow
9.77B
Total cash
4.88B
Total debt
26.25B
Return on equity
-20.68%
Shares outstanding
1.24B
Short % of float
1.64%
50-day average
150.33
200-day average
139.65

Analyst view

Consensus: buy

Buy
Price target (mean) 160.19 -6.1% downside
Target (low)
126.00
Target (mean)
160.19
Target (high)
185.00
Ratings (0m) 28 22 buy · 5 hold · 1 sell
  • Strong buy6
  • Buy16
  • Hold5
  • Sell0
  • Strong sell1

Next earnings

Feb 9, 2027

Expected Feb 9, 2027. Consensus EPS estimate 2.03.

Earnings history

Financials — quick view

All financials
GILD Revenue — quarterly 8.30B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
GILD Net income — quarterly 2.43B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
GILD EPS — quarterly 1.96
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

GILD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 9, 2027Dec 30, 20262.05———
Oct 29, 2026Sep 30, 20262.192.55+0.36+16.44%
Aug 3, 2026Jun 30, 2026-7.25-6.75+0.50+6.90%
May 7, 2026Mar 31, 20261.912.03+0.12+6.28%
Feb 10, 2026Dec 31, 20251.811.86+0.05+2.76%
Oct 30, 2025Sep 30, 20252.132.47+0.34+15.96%

Upgrades / downgrades

GILD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026TD CowenmainBuyBuy
Oct 30, 2026Morgan StanleymainOverweightOverweight
Oct 30, 2026Wells FargomainOverweightOverweight
Oct 30, 2026Truist SecuritiesmainBuyBuy
Oct 30, 2026RBC CapitalmainSector PerformSector Perform
Oct 30, 2026Cantor FitzgeraldmainOverweightOverweight

About Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company has a partnership with Pan American Health Organization (PAHO) to accelerate access to lenacapavir for HIV prevention as pre-exposure prophylaxis (PrEP) across all PAHO member states in Latin America and the Caribbean. The company was incorporated in 1987 and is headquartered in Foster City, California.

Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United States
Website
gilead.com

News

Your note

Sign in to keep a note on GILD — it syncs with the Stock Master app.

Insider holders

GILD insider holders
InsiderRelationLatest transactionDateShares held
BARTON JACQUELINE KDirectorStock Award(Grant)Apr 29, 202627,202
BERGER DIETMAR P.OfficerConversion of Exercise of derivative securitySep 9, 202619,522
DICKINSON ANDREW DChief Financial OfficerSaleSep 14, 2026164,096
MANWANI HARISHDirectorStock Award(Grant)Apr 29, 202615,015
MERCIER JOHANNAOfficerSaleSep 14, 2026116,684
O'DAY DANIEL PATRICKChief Executive OfficerConversion of Exercise of derivative securitySep 9, 2026581,683

Institution ownership

GILD institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.83%121,844,10820.80BJun 29, 2026
Vanguard Capital Management LLC6.54%81,091,73413.84BJun 29, 2026
FMR, LLC5.39%66,870,81611.41BJun 29, 2026
State Street Corporation4.94%61,216,55210.45BJun 29, 2026
Capital World Investors3.31%40,988,9757.00BJun 29, 2026
Invesco Ltd.3.21%39,819,1516.80BJun 29, 2026

Fund ownership

GILD fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.18%39,416,8936.73BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%32,173,7505.49BJun 29, 2026
Invesco QQQ Trust, Series 12.09%25,899,6724.42BSep 29, 2026
Dodge & Cox Funds-Dodge & Cox Stock Fund1.39%17,282,8122.95BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%16,522,3152.82BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%16,116,6982.75BAug 30, 2026
Advertisement